Compass Therapeutics (CMPX) Insider Trading & Ownership $1.82 -0.04 (-2.15%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$1.84 +0.02 (+1.10%) As of 08:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Compass Therapeutics (NASDAQ:CMPX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage28.50%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$30,800.00Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$5.68 M Get CMPX Insider Trade Alerts Want to know when executives and insiders are buying or selling Compass Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CMPX Insider Buying and Selling by Quarter Compass Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/9/2025Carl L GordonDirectorSell3,571,428$1.59$5,678,570.52 4/7/2025Jonathan AndermanInsiderBuy20,000$1.54$30,800.00 (Data available from 1/1/2013 forward) CMPX Insider Trading Activity - Frequently Asked Questions Who is on Compass Therapeutics's Insider Roster? The list of insiders at Compass Therapeutics includes Carl L Gordon, Jonathan Anderman, Orbimed Advisors Llc, Thomas J Schuetz, and Vered Bisker-Leib. Learn more on insiders at CMPX. What percentage of Compass Therapeutics stock is owned by insiders? 28.50% of Compass Therapeutics stock is owned by insiders. Learn more on CMPX's insider holdings. Which Compass Therapeutics insiders have been buying company stock? The following insider purchased CMPX shares in the last 24 months: Jonathan Anderman ($30,800.00). How much insider buying is happening at Compass Therapeutics? Insiders have purchased a total of 20,000 CMPX shares in the last 24 months for a total of $30,800.00 bought. Which Compass Therapeutics insiders have been selling company stock? The following insider sold CMPX shares in the last 24 months: Carl L Gordon ($5,678,570.52). How much insider selling is happening at Compass Therapeutics? Insiders have sold a total of 3,571,428 Compass Therapeutics shares in the last 24 months for a total of $5,678,570.52 sold. Compass Therapeutics Key ExecutivesDr. Vered Bisker-Leib M.D. (Age 53)MBA, Ph.D., CEO & Director Compensation: $719kDr. Thomas J. Schuetz M.D. (Age 63)Ph.D., Co-Founder, President of Research & Development and Vice Chairman of the Board Compensation: $835.88kMr. Neil L. Lerner CPA (Age 57)Vice President of Finance Mr. Jonathan Anderman J.D.VP, Head of Legal & Corporate Secretary1 recent tradesAnna GiffordCommunications ManagerDr. Minori Rosales M.D. (Age 61)Ph.D., Senior VP & Head of Clinical Development Ms. Karin Herrera B.A.VP & Head of Clinical OperationsDr. James Kranz Ph.D.VP and Head of Chemistry Manufacturing & Controls More Insider Trading Tools from MarketBeat Related Companies WVE Insider Trades ETNB Insider Trades COLL Insider Trades MLYS Insider Trades NTLA Insider Trades SYRE Insider Trades ZYME Insider Trades RCUS Insider Trades NRIX Insider Trades CMRX Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles McDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why This page (NASDAQ:CMPX) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compass Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Compass Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CMPX Stock Free CMPX Stock Alerts